Horizon Pharma (HZNP) Tops Q2 EPS by 11c

Horizon Pharma (NASDAQ: HZNP) reported Q2 EPS of $0.21, $0.11 better than the analyst estimate of $0.10. Revenue for the quarter came in at $66.1 million versus the consensus estimate of $58.35 million.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• JPMorgan Upgrades Kolmar Korea Co Ltd (161890:KS) to Overweight
• JD.com earnings preview: stronger profit expected, macro headwinds in focus